Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine plus vitamin D3 versus vitamin D3 alone for recurrent miscarriage
IRCT20250507065634N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hydroxychloroquine and vitamin d in recurrent miscarriage (RPL) and Pregnancy loss (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Frequency of ongoing pregnancy. Started Sep 2025; status: completed.
02
Drugs
hydroxychloroquinevitamin d
03
Conditions
recurrent miscarriage (RPL)Pregnancy loss
Beyond the preview
Go deeper on IRCT20250507065634N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250507065634N3.